Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

The Journal of Clinical Investigation
J SchirraM Katschinski

Abstract

The gastrointestinal hormone, glucagon-like peptide-1(7-36)amide (GLP-1) is released after a meal. The potency of synthetic GLP-1 in stimulating insulin secretion and in inhibiting glucagon secretion indicates the putative physiological function of GLP-1. In vitro, the nonmammalian peptide, exendin(9-39)amide [ex(9-39)NH2], is a specific and competitive antagonist of GLP-1. This in vivo study examined the efficacy of ex(9-39)NH2 as an antagonist of exogenous GLP-1 and the physiological role of endogenous GLP-1. Six healthy volunteers underwent 10 experiments in random order. In each experiment, a 30-min period of euglycemia was followed by an intravenous infusion of glucose for 150 min that established a stable hyperglycemia of 8 mmol/liter. There was a concomitant intravenous infusion of one of the following: (1) saline, (2) GLP-1 (for 60 min at 0.3 pmol . kg-1 . min-1 that established physiological postprandial plasma levels, and for another 60 min at 0.9 pmol . kg-1 . min-1 to induce supraphysiological plasma levels), (3-5) ex(9-39)NH2 at 30, 60, or 300 pmol . kg-1 . min-1 + GLP-1, (6-8) ex(9-39)NH2 at 30, 60, or 300 pmol . kg-1 . min-1 + saline, (9 and 10) GIP (glucose-dependent insulinotropic peptide; for 60 min at 0.8 pmo...Continue Reading

References

Apr 1, 1991·European Journal of Clinical Investigation·R GökeB Göke
Jul 1, 1990·The Journal of Endocrinology·D J O'HalloranS R Bloom
May 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·D J DruckerJ F Habener
Jan 1, 1995·The Journal of Clinical Investigation·Z WangS R Bloom
Jan 1, 1993·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·R GökeB Göke
Jan 1, 1996·The Journal of Clinical Investigation·J SchirraB Göke
Aug 22, 1997·The Journal of Biological Chemistry·C Montrose-RafizadehJ Eng

❮ Previous
Next ❯

Citations

Apr 29, 2010·Current Diabetes Reports·Dima L Diab, David A D'Alessio
Jul 7, 2012·Current Diabetes Reports·Claire M Issa, Sami T Azar
Jan 2, 2007·Southern Medical Journal·Nasser Mikhail
Aug 17, 2011·Diabetes, Obesity & Metabolism·D D'Alessio
Apr 9, 2008·International Journal of Clinical Practice. Supplement·B Göke
Jan 13, 2006·Gut·M Horowitz, M A Nauck
May 22, 2008·American Journal of Physiology. Endocrinology and Metabolism·Viorica IonutRichard N Bergman
Jan 4, 2007·The Journal of Clinical Investigation·Daniel J Drucker
Oct 2, 2008·The Journal of Clinical Endocrinology and Metabolism·Marzieh SalehiDavid A D'Alessio
Aug 27, 2009·Therapeutics and Clinical Risk Management·Joan KhooMichael Horowitz
Mar 16, 2005·Treatments in Endocrinology·Laurie L Baggio, Daniel J Drucker
Aug 19, 2011·The American Journal of Clinical Nutrition·Guillaume CarrelLuc Tappy
Jan 21, 2014·The Journal of Endocrinology·Antonella AmatoFlavia Mulè
Jan 9, 2003·Expert Opinion on Investigational Drugs·Daniel J Drucker
Mar 12, 2004·Expert Opinion on Investigational Drugs·Torsten P Vahl, David A D'Alessio
Aug 15, 2009·Expert Opinion on Investigational Drugs·Kjetil Retterstøl
Jul 19, 2013·Archives of Physiology and Biochemistry·Giuseppina OpintoPiero Marchetti
Jun 5, 2012·Pharmacology & Therapeutics·Young Min ChoTimothy J Kieffer
Nov 17, 2011·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Myriam JeanAbderrazzak Merzouki
Apr 23, 2010·Journal of the American Society of Hypertension : JASH·Kiwon BanMansoor Husain
Sep 13, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Jack HouJohn H Zhang
May 15, 2007·Gastroenterology·Laurie L Baggio, Daniel J Drucker
Nov 30, 2006·Peptides·Ixchel M BrennanChristine Feinle-Bisset
Feb 18, 2009·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·J SchirraB Göke
May 2, 2012·Annals of the New York Academy of Sciences·Liza K Phillips, Johannes B Prins
May 18, 2016·Journal of Diabetes Investigation·David D'Alessio
Jul 6, 2014·Diabetes/metabolism Research and Reviews·Hale M TasyurekSalih Sanlioglu
Nov 10, 2004·Best Practice & Research. Clinical Endocrinology & Metabolism·Laurie L Baggio, Daniel J Drucker

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.